Press "Enter" to skip to content

New patent for Gilead Sciences drug VEKLURY

0
Copyright © DrugPatentWatch. Originally published at New patent for Gilead Sciences drug VEKLURY

Annual Drug Patent Expirations for VEKLURY
Annual Drug Patent Expirations for VEKLURY

Veklury is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from one supplier. There are ten patents protecting this drug.

This drug has two hundred and forty-three patent family members in forty-five countries.

The generic ingredient in VEKLURY is remdesivir. One supplier is listed for this compound. Additional details are available on the remdesivir profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Gilead Sciences drug VEKLURY
Find your next blockbuster

Get accurate and timely intelligence — in just a few clicks

✓ Free trial

✓ No credit card

 

DrugPatentWatch - Make Better Decisions